Oromandibular Dystonia: Demographics and Clinical Data from 240 Patients
Linda Slaim, Myriam Cohen, Patrick Klap, Marie Vidailhet, Alain Perrin, Daniel Brasnu, Denis Ayache, Marie Mailly
JMD. 2018;11(2):78-81.   Published online 2018 May 30     DOI: https://doi.org/10.14802/jmd.17065
Citations to this article as recorded by Crossref logo
Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis
Pariessa D. Dadgardoust, Raymond L. Rosales, Ria Monica Asuncion, Dirk Dressler
Journal of Neural Transmission.2019; 126(2): 141.     CrossRef
Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features
Kazuya Yoshida
Toxins.2019; 11(1): 51.     CrossRef
Oromandibular dystonia, mental distress and oro‐facial dysfunction—A follow‐up 8‐10 years after start of treatment with botulinum toxin
Merete Bakke, Sara Baram, Torben Dalager, Heidi Bryde Biernat, Eigild Møller
Journal of Oral Rehabilitation.2019; 46(5): 441.     CrossRef
Pseudodystonia: A new perspective on an old phenomenon
Rok Berlot, Kailash P. Bhatia, Maja Kojović
Parkinsonism & Related Disorders.2019;[Epub]     CrossRef